BC-1901S

CAT: 0804-HY-160876-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-160876-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BC-1901S is a proteasome-independent NRF2 activator and stabilizer. BC-1901S binds to DCAF1 (E3 ligase subunit) and disrupts NRF2/DCAF1 interaction, and activates NRF2 by inhibiting NRF2 ubiquitination in a KEAP1-independent manner. BC-1901S shows anti-inflammatory effect in a murine model of LPS-induced acute lung injury[1].
CAS Number
[1358617-36-3]
UNSPSC
12352005
Target
E1/E2/E3 Enzyme; Keap1-Nrf2
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bc-1901s.html
Purity
99.81
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1CCN(CC1)C2=NC(C3=CC(C)=CC=C3)=NC=C2)NC4=CC=C(C(Cl)=C4)F
Molecular Formula
C23H22ClFN4O
Molecular Weight
424.90
References & Citations
[1]Chen Y, et al. A small molecule NRF2 activator BC-1901S ameliorates inflammation through DCAF1/NRF2 axis. Redox Biol. 2020 May;32:101485.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-149514BC-05
HY-D2953BC-CPY
HY-P991331BC-010
HY-119288-01BC-23
HY-W128219-01BC-NH2
HY-161901BC-1293
HY-114366-01BC-1485
HY-W062696-01BC-1382
HY-113640-01BC-7013
HY-D2959BC-DF

Alternative Products

CatalogName
T87995-01BC-1901S
MBS3605379-01BC-23
T8956-01BC-?1258
T89425-01BC-1293
T9901A-1659-01BC-010
MBS5759350BC-1382
TRC-B358215-250MGBC-1471
MBS5774875BC 197
BUP01020-01BC-1485
BA3188-100BC-1258

Popular Products